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A remarkably prescient paper published by Robert Williamson
in 1970 was the ﬁrst description and correct interpretation of
both the apoptotic origin of cell-free DNA and the subunit
structure of chromatin. Thus, the original observation that
forms the basis for this powerful precision medicine strategy
also played a central role in the discovery of the nucleosome.
Many seminal discoveries are overlooked because theyare ahead of their time (STENT1972). Herewe present
one of these stories: the dual discovery of the origin of cell-
free DNA and the subunit structure of chromatin.
cfDNA fromhuman plasma is a noninvasive diagnostic tool
that is rapidly becoming a standard in the clinic. Prenatal
diagnosis for chromosome abnormalities and some single-
gene disorders is now routinely done by assaying fetal cfDNA
in the mother’s blood plasma (Bunkar et al. 2018). After
organ transplantation, cfDNA from the donor allograft re-
leased into the plasma can serve as a sentinel of rejection
(Snyder et al. 2011; Daly 2015; Bloom et al. 2017; Schütz
et al. 2017). Apoptosis within a tumor results in the release of
sufﬁcient cfDNA into the plasma or cerebral spinal ﬂuid to
monitor the course of treatment (Diaz and Bardelli 2014;
Cohen et al. 2018). The continuing reduction in the cost of
DNA sequencing is bringing cfDNA assays into the clinic for
the diagnosis of cancer andmany other diseases. Thus, cfDNA
assays are key drivers of the current personalized medicine
revolution.
Although the detection of cfDNA in plasma was ﬁrst de-
scribed two decades ago (Lo et al. 1997), its generation in
dying cells was observed much earlier. In 1970, Robert
Williamson described what is now familiar as the “nucleo-
some ladder” in the cytoplasmic fraction of embryonic mouse
liver (Williamson 1970). This dual discovery, which presaged
the development of two different research ﬁelds, was moti-
vated by Williamson’s attempts to isolate globin mRNA from
reticulocytes, where he was stymied by contamination with
cytoplasmic DNA fragments. His curiosity about the source of
cytoplasmic DNA contamination, and about various sugges-
tions that cytoplasmic DNAmight bemetabolically active and
“functional” akin to mRNA, led him to a systematic study
of cytoplasmic DNA. His protocol was simple: excision of
embryonic mouse livers, culturing in [32P]phosphate- or
[3H]thymidine-containing medium, lysis and centrifugation
to separate nuclei from cytoplasm, and extraction of DNA
from the supernatant and pellet. He then characterized the
labeled DNA from the cytoplasmic and nuclear fractions by
buoyant density centrifugation, polyacrylamide gel electro-
phoresis (PAGE), DNA depurination ﬁngerprinting, and base
composition analysis. In this way, he could compare the phys-
ical, informational, and metabolic properties of cytoplasmic
DNA and nuclear DNA.
Williamson’s thorough characterization of cytoplasmic
DNA using tools available at the time showed that the cyto-
plasmic DNA was similar to nuclear DNA in buoyant density
and base composition, ruling out mitochondrial contamina-
tion, and complex ﬁngerprints indicated that it was composed
of many different sequences. However, unlike most nuclear
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DNA, cytoplasmic DNA showed a remarkable electrophoretic
pattern, a regular ladder of up to 10 bands (Figure 1). This
ladder was sensitive to DNase (Figure 1, A and B), resistant to
RNase (Figure 1, C and D), and detectable as a minor com-
ponent of nuclear DNA (Figure 1E). The electrophoretic
mobility of the bands fell on a straight line on a log Mw
vs. distance plot, revealing that the fragments corresponded
to a series of multiples of a unit length. His estimated Mw =
135,000 for the difference between bands corresponds to
200 bp of DNA, the repeat unit that later work showed is
the nucleosome repeat length. This left the question: what
was its origin?
Because cytoplasmic DNA accounted for as much as 20%
of the total DNA in his cultures,Williamson concluded that it
was unlikely to consist of replication intermediates. Autora-
diography of embryonic liver labeled for 16 hr showed that
whereas 30% of the cells were labeled in the nucleus, only
15% of the cells also displayed cytoplasmic labeling, which
suggested toWilliamson that this subset of cells comprised a
distinct class ofmetabolically active cells. Noting that 14 and
1/2day-old embryonic liver consistsmostly of erythroid cells
at several stages of development, he proposed that DNA
fragmentation is associated with disintegration of nuclei
in dying cells. Although this was 2 years before the term
apoptosis was coined (Kerr et al. 1972), and long before
apoptotic pathways were delineated, Williamson’s interpre-
tation of the cytoplasmic DNA as deriving from nuclear dis-
integration during cell death is now considered to be
correct. For example, cfDNA from plasma shows the same
nucleosome ladder as Williamson observed, and analysis of
internucleosomal distances (Snyder et al. 2016) and subnu-
cleosomal intermediates (Ramachandran et al. 2017) as
DNA proxies for gene expression conﬁrms the hematopoi-
etic origin of the apoptotic cells. The simultaneous discovery
of the nucleosome ladder and the origin of cfDNA in
1970 was thus correctly interpreted by Williamson, respec-
tively 3 years and nearly 3 decades before the biological
signiﬁcance of nucleosomes and the clinical utility of cfDNA
were appreciated.
Williamson’s dual discovery was published in the Journal
of Molecular Biology, the premier molecular biology journal of
the day; however, it has remained surprisingly underappre-
ciated relative to subsequent papers that built upon its ﬁnd-
ings. As described by Kornberg and Klug in a Scientiﬁc
American article in 1981 (Kornberg and Klug 1981), William-
son’s discovery of the nucleosome ladder was a key insight
that led to the nucleosome model: “. . .he had reported sizes
for the DNA fragments that were multiples of 200 nucleo-
tide pairs. The agreement with the size of fragments expected
from the beads-on-a-string idea was remarkably good. From
this moment on it seemed the idea must be right.” Yet, the
discovery of the nucleosome ladder is widely attributed to a
brief 1973 report of the ladder resulting from the in situ
action of an endogenous nuclease by Hewish and Burgoyne
Figure 1 PAGE analysis (2.4%) of
DNA fragments from embryonic
mouse liver. (A) Total cytoplasmic
nucleic acid; (B) same after treat-
ment with DNase; (C) same after
treatment with RNase; (D) puri-
ﬁed cytoplasmic DNA (after RNase
treatment of total cytoplasmic nucleic
acid and passage through Biogel
P30 column; and (E) 141/2-day nu-
clear DNA. Reproduced with per-
mission from Williamson (1970).
28 S. Henikoff and G. M. Church
(1973), despite the fact that they did not report the repeat
length. In a 1982 interview, Hewish gave credit to William-
son: “. . .we were inﬂuenced by a previous publication of
Williamson, who had described a regular series of size classes
among DNA fragments in the cytoplasm of cultured cells”
(Hewish 1982).
Although Williamson’s seminal ﬁndings were eventually
recognized in the apoptosis ﬁeld (Duke et al. 1983), his
1970 paper is cited only 1/10th as frequently as Hewish
and Burgoyne’s, and almost never for its discovery of the
nucleosome ladder. The reasons for the paper’s relative ob-
scurity are unclear. In Understanding DNA: The Molecule and
How it Works, Calladine et al. (2004) asserted that “he
thought that these fragments might come from the incom-
plete synthesis of long DNA molecules, as shown by previous
work, rather than from the degradation of intact chromo-
somes. Because of this his work attracted little attention.”
However, this interpretation was one of many that William-
son considered but judged to be unlikely. Leaving no doubt as
to what he thought, Williamson’s abstract closed with the
sentence: “These ﬁndings are consistent with a hypothesis
that in this system the DNA isolated from the cytoplasm is a
degradation product of nuclear DNA.” Perhaps a more plau-
sible reason for the paper’s obscurity in the chromatin ﬁeld
was an inﬂuentialNature paper entitled “Subunit structure of
chromatin” (Noll 1974), which demonstrated the 200-bp re-
peat unit of the ladder, but cited Hewish and Burgoyne’s
1973 paper as prior work, and later authors followed suit.
Although Williamson maintained a thriving laboratory
subsequent topublicationofhis1970paper, henever followed
up on its ﬁndings. He has attributed his own lack of interest in
the DNA ladder to its being a “structural,” not a “functional,”
feature of DNA, and has credited those who realized its sig-
niﬁcance for developing the nucleosome model that has had
such a huge impact in understanding eukaryotic biology.
While his modesty is perhaps justiﬁed with respect to the part
his discovery played in developing the nucleosome model, he
deserves full credit for the correctness of his interpretation of
what we now know to be the apoptotic origin of cfDNA. As the
clinical importance of cfDNA becomes increasingly manifest,
Williamson’s pioneering insights from nearly 50 years ago take
on increasing signiﬁcance and merit growing admiration.
Acknowledgments
We thank Bob Williamson for sharing his recollections.
Literature Cited
Bloom, R. D., J. S. Bromberg, E. D. Poggio, S. Bunnapradist, A. J.
Langone et al., 2017 Cell-free DNA and active rejection in kid-
ney allografts. J. Am. Soc. Nephrol. 28: 2221–2232. https://doi.
org/10.1681/ASN.2016091034
Bunkar, N., A. Bhargava, K. Chaudhury, R. S. Sharma, N. K. Lohiya
et al., 2018 Fetal nucleic acids in maternal plasma: from bi-
ology to clinical translation. Front. Biosci. 23: 397–431. https://
doi.org/10.2741/4597
Calladine, C. R., H. Drew, B. Luisi, and A. Travers, 2004 Understanding
DNA: The Molecule and How it Works. Academic Press, New York.
Cohen, J. D., L. Li, Y. Wang, C. Thoburn, B. Afsari et al.,
2018 Detection and localization of surgically resectable
cancers with a multi-analyte blood test. Science 359: 926–
930. https://doi.org/10.1126/science.aar3247
Daly, K. P., 2015 Circulating donor-derived cell-free DNA: a
true biomarker for cardiac allograft rejection? Ann. Transl.
Med. 3: 47.
Diaz, L. A., Jr., and A. Bardelli, 2014 Liquid biopsies: genotyping
circulating tumor DNA. J. Clin. Oncol. 32: 579–586. https://doi.
org/10.1200/JCO.2012.45.2011
Duke, R. C., R. Chervenak, and J. J. Cohen, 1983 Endogenous
endonuclease-induced DNA fragmentation: an early event in
cell-mediated cytolysis. Proc. Natl. Acad. Sci. USA 80: 6361–
6365. https://doi.org/10.1073/pnas.80.20.6361
Hewish, D. R., 1982 This week’s citation classic. Current Contents.
Available at: http://garﬁeld.library.upenn.edu/classics1982/
A1982MY11300001.pdf. Accessed January 6, 2018.
Hewish, D. R., and L. A. Burgoyne, 1973 Chromatin sub-structure.
The digestion of chromatin DNA at regularly spaced sites by a
nuclear deoxyribonuclease. Biochem. Biophys. Res. Commun.
52: 504–510. https://doi.org/10.1016/0006-291X(73)90740-7
Kerr, J. F., A. H. Wyllie, and A. R. Currie, 1972 Apoptosis: a basic
biological phenomenon with wide-ranging implications in tissue
kinetics. Br. J. Cancer 26: 239–257. https://doi.org/10.1038/
bjc.1972.33
Kornberg, R. D., and A. Klug, 1981 The nucleosome. Sci. Am. 244:
52–64. https://doi.org/10.1038/scientiﬁcamerican0281-52
Lo, Y. M., N. Corbetta, P. F. Chamberlain, V. Rai, I. L. Sargent et al.,
1997 Presence of fetal DNA inmaternal plasma and serum. Lancet
350: 485–487. https://doi.org/10.1016/S0140-6736(97)02174-0
Noll, M., 1974 Subunit structure of chromatin. Nature 251: 249–
251. https://doi.org/10.1038/251249a0
Ramachandran, S., K. Ahmad, and S. Henikoff, 2017 Transcription
and remodeling produce asymmetrically unwrapped nucleosomal
intermediates. Mol. Cell 68: 1038–1053.e4. https://doi.org/10.
1016/j.molcel.2017.11.015
Schütz, E., A. Fischer, J. Beck, M. Harden, M. Koch et al.,
2017 Graft-derived cell-free DNA, a noninvasive early rejection
and graft damage marker in liver transplantation: a prospective,
observational, multicenter cohort study. PLoS Med. 14: e1002286.
https://doi.org/10.1371/journal.pmed.1002286
Snyder, M. W., M. Kircher, A. J. Hill, R. M. Daza, and J. Shendure,
2016 Cell-free DNA comprises an in vivo nucleosome footprint
that informs its tissues-of-origin. Cell 164: 57–68. https://doi.
org/10.1016/j.cell.2015.11.050
Snyder, T. M., K. K. Khush, H. A. Valantine, and S. R. Quake,
2011 Universal noninvasive detection of solid organ trans-
plant rejection. Proc. Natl. Acad. Sci. USA 108: 6229–6234.
https://doi.org/10.1073/pnas.1013924108
Stent, G. S., 1972 Prematurity and uniqueness in scientiﬁc discov-
ery. Sci. Am. 227: 84–93. https://doi.org/10.1038/scientiﬁca-
merican1272-84
Williamson, R., 1970 Properties of rapidly labelled deoxyribonu-
cleic acid fragments isolated from the cytoplasm of primary
cultures of embryonic mouse liver cells. J. Mol. Biol. 51: 157–
168. https://doi.org/10.1016/0022-2836(70)90277-9
Communicating editor: M. Johnston
Commentary 29
